{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:14:28Z","timestamp":1760300068862},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Acute Heart Failure Specialist","award":["20162002"],"award-info":[{"award-number":["20162002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.1007\/s40256-018-0304-1","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T03:26:12Z","timestamp":1537845972000},"page":"211-218","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study"],"prefix":"10.1007","volume":"19","author":[{"given":"Fang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangmin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhou","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"issue":"1","key":"304_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12574-014-0236-y","volume":"13","author":"C Izumi","year":"2015","unstructured":"Izumi C. Tricuspid regurgitation following left-sided valve surgery: echocardiographic evaluation and optimal timing of surgical treatment. J Echocardiogr. 2015;13(1):15\u20139. https:\/\/doi.org\/10.1007\/s12574-014-0236-y.","journal-title":"J Echocardiogr"},{"issue":"5","key":"304_CR2","doi-asserted-by":"publisher","first-page":"1234.e5","DOI":"10.1016\/j.jtcvs.2012.01.088","volume":"145","author":"LM Vargas Abello","year":"2013","unstructured":"Vargas Abello LM, Klein AL, Marwick TH, Nowicki ER, Rajeswaran J, Puwanant S, et al. Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease. J Thorac Cardiovasc Surg. 2013;145(5):1234.e5\u20131241.e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.01.088.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"304_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.pcad.2008.08.009","volume":"51","author":"KM Chan","year":"2009","unstructured":"Chan KM, Zakkar M, Amirak E, Punjabi PP. Tricuspid valve disease: pathophysiology and optimal management. Prog Cardiovasc Dis. 2009;51(6):482\u20136. https:\/\/doi.org\/10.1016\/j.pcad.2008.08.009.","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"304_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.healun.2007.12.011","volume":"27","author":"RC Wong","year":"2008","unstructured":"Wong RC, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R, et al. Tricuspid regurgitation after cardiac transplantation: an old problem revisited. J Heart Lung Transplant. 2008;27(3):247\u201352. https:\/\/doi.org\/10.1016\/j.healun.2007.12.011.","journal-title":"J Heart Lung Transplant."},{"issue":"12","key":"304_CR5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1586\/erc.11.163","volume":"9","author":"L Gargani","year":"2011","unstructured":"Gargani L, Schmidt PH, Gheorghiade M. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion. Expert Rev Cardiovasc Ther. 2011;9(12):1505\u201313. https:\/\/doi.org\/10.1586\/erc.11.163.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"12","key":"304_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","volume":"17","author":"JE Udelson","year":"2011","unstructured":"Udelson JE, Bilsker M, Hauptman PJ, Sequeira R, Thomas I, O\u2019Brien T, et al. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction. J Card Fail. 2011;17(12):973\u201381. https:\/\/doi.org\/10.1016\/j.cardfail.2011.08.005.","journal-title":"J Card Fail"},{"issue":"1","key":"304_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-3466.2007.00001.x","volume":"25","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist\u2014pharmacology and clinical trials. Cardiovasc Drug Rev. 2007;25(1):1\u201313. https:\/\/doi.org\/10.1111\/j.1527-3466.2007.00001.x.","journal-title":"Cardiovasc Drug Rev"},{"issue":"11","key":"304_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.amjcard.2006.06.051","volume":"98","author":"S Payvar","year":"2006","unstructured":"Payvar S, Orlandi C, Stough WG, Elkayam U, Ouyang J, Casscells SW, et al. Comparison of 60-day mortality in hospitalized heart failure patients with versus without hypothermia. Am J Cardiol. 2006;98(11):1485\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2006.06.051.","journal-title":"Am J Cardiol"},{"issue":"12","key":"304_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297(12):1319\u201331. https:\/\/doi.org\/10.1001\/jama.297.12.1319.","journal-title":"JAMA."},{"issue":"12","key":"304_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/jcph.197","volume":"53","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide. J Clin Pharmacol. 2013;53(12):1277\u201385. https:\/\/doi.org\/10.1002\/jcph.197.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"304_CR11","first-page":"1","volume":"11","author":"H Zulkifli Amin","year":"2016","unstructured":"Zulkifli Amin H, Suridanda Danny S. Tolvaptan: a novel diuretic in heart failure management. J Tehran Heart Center. 2016;11(1):1\u20135.","journal-title":"J Tehran Heart Center."},{"issue":"suppl_1","key":"304_CR12","doi-asserted-by":"publisher","first-page":"P3338-P","DOI":"10.1093\/eurheartj\/eht309.P3338","volume":"34","author":"Y Ikeda","year":"2013","unstructured":"Ikeda Y, Inomata T, Iida Y, Nabeta T, Iwamoto M, Ishii S, et al. The vasopressin V2-receptor antagonist, tolvaptan, can not only induce aquaresis but also enhance natriuresis in heart failure patients refractory to loop diuretics. Eur Heart J. 2013;34(suppl_1):P3338-P. https:\/\/doi.org\/10.1093\/eurheartj\/eht309.p3338.","journal-title":"Eur Heart J"},{"issue":"8","key":"304_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/pace.12160","volume":"36","author":"Y Rodriguez","year":"2013","unstructured":"Rodriguez Y, Mesa J, Arguelles E, Carrillo RG. Tricuspid insufficiency after laser lead extraction. Pacing Clin Electrophysiol PACE. 2013;36(8):939\u201344. https:\/\/doi.org\/10.1111\/pace.12160.","journal-title":"Pacing Clin Electrophysiol PACE."},{"issue":"9 Suppl","key":"304_CR14","doi-asserted-by":"publisher","first-page":"I453","DOI":"10.1161\/CIRCULATIONAHA.104.524421","volume":"112","author":"A Matsunaga","year":"2005","unstructured":"Matsunaga A, Duran CM. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005;112(9 Suppl):I453\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.524421.","journal-title":"Circulation."},{"issue":"4","key":"304_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00595-016-1395-4","volume":"47","author":"H Takano","year":"2017","unstructured":"Takano H, Hiramatsu M, Kida H, Uenoyama M, Horiguchi K, Yamauchi T, et al. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today. 2017;47(4):445\u201356. https:\/\/doi.org\/10.1007\/s00595-016-1395-4.","journal-title":"Surg Today."},{"issue":"11","key":"304_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/hrt.2008.152793","volume":"95","author":"H Song","year":"2009","unstructured":"Song H, Kim MJ, Chung CH, Choo SJ, Song MG, Song JM, et al. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart. 2009;95(11):931\u20136. https:\/\/doi.org\/10.1136\/hrt.2008.152793.","journal-title":"Heart."},{"issue":"21","key":"304_CR17","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107(21):2690\u20136. https:\/\/doi.org\/10.1161\/01.cir.0000070422.41439.04.","journal-title":"Circulation."},{"issue":"9","key":"304_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","volume":"174","author":"PR Forfia","year":"2006","unstructured":"Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174(9):1034\u201341. https:\/\/doi.org\/10.1164\/rccm.200604-547OC.","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"304_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12574-017-0330-z","volume":"15","author":"T Niwa","year":"2017","unstructured":"Niwa T, Waseda K, Mizuno T, Nakano Y, Mukai K, Wakabayashi H, et al. Predictability of tricuspid annular plane systolic excursion for the effectiveness of tolvaptan in patients with heart failure. J Echocardiogr. 2017;15(3):118\u201326. https:\/\/doi.org\/10.1007\/s12574-017-0330-z.","journal-title":"J Echocardiogr"},{"issue":"4","key":"304_CR20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1253\/circj.CJ-14-0126","volume":"78","author":"K Kinugawa","year":"2014","unstructured":"Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J. 2014;78(4):844\u201352.","journal-title":"Circ J"},{"issue":"16","key":"304_CR21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","volume":"291","author":"M Gheorghiade","year":"2004","unstructured":"Gheorghiade M, Gattis WA, O\u2019Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291(16):1963\u201371. https:\/\/doi.org\/10.1001\/jama.291.16.1963.","journal-title":"JAMA."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-018-0304-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:35:10Z","timestamp":1628616910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-018-0304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,8]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s40256-018-0304-1","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"25 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Fang Yuan, Zhangmin Wu, Li Jiang, Jun Zhou, Lei Xu, Hua Liu, Lan Ma, Zhenzhou Zhai, and Junjie Zhang have no conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All data generated or analyzed during this study are included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was funded by the Acute Heart Failure Specialist (Grant number: 20162002).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}